These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9545146)

  • 1. Population pharmacokinetics of carbamazepine in adults with epilepsy.
    Graves NM; Brundage RC; Wen Y; Cascino G; So E; Ahman P; Rarick J; Krause S; Leppik IE
    Pharmacotherapy; 1998; 18(2):273-81. PubMed ID: 9545146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenobarbital pharmacokinetics in old age: a case-matched evaluation based on therapeutic drug monitoring data.
    Messina S; Battino D; Croci D; Mamoli D; Ratti S; Perucca E
    Epilepsia; 2005 Mar; 46(3):372-7. PubMed ID: 15730534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum carbamazepine concentrations in elderly patients: a case-matched pharmacokinetic evaluation based on therapeutic drug monitoring data.
    Battino D; Croci D; Rossini A; Messina S; Mamoli D; Perucca E
    Epilepsia; 2003 Jul; 44(7):923-9. PubMed ID: 12823575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors influencing topiramate clearance in adult patients with epilepsy: A population pharmacokinetic analysis.
    Bae EK; Lee J; Shin JW; Moon J; Lee KJ; Shin YW; Kim TJ; Shin D; Jang IJ; Lee SK
    Seizure; 2016 Apr; 37():8-12. PubMed ID: 26908152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discontinuation of phenytoin and carbamazepine in patients receiving felbamate.
    Wagner ML; Graves NM; Marienau K; Holmes GB; Remmel RP; Leppik IE
    Epilepsia; 1991; 32(3):398-406. PubMed ID: 1904346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population pharmacokinetics of carbamazepine in Singapore epileptic patients.
    Chan E; Lee HS; Hue SS
    Br J Clin Pharmacol; 2001 Jun; 51(6):567-76. PubMed ID: 11422016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a population pharmacokinetic model for carbamazepine based on sparse therapeutic monitoring data from pediatric patients with epilepsy.
    Carlsson KC; Hoem NO; Glauser T; Vinks AA
    Clin Ther; 2005 May; 27(5):618-26. PubMed ID: 15978311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetics of steady-state carbamazepine in Egyptian epilepsy patients.
    El Desoky ES; Sabarinath SN; Hamdi MM; Bewernitz M; Derendorf H
    J Clin Pharm Ther; 2012 Jun; 37(3):352-5. PubMed ID: 21883329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic modeling of valproate from clinical data in Serbian epileptic patients.
    Jankovic SM; Milovanovic JR
    Methods Find Exp Clin Pharmacol; 2007 Dec; 29(10):673-9. PubMed ID: 18200330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of felbamate on phenytoin and carbamazepine serum concentrations.
    Graves NM; Holmes GB; Fuerst RH; Leppik IE
    Epilepsia; 1989; 30(2):225-9. PubMed ID: 2647472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steady state pharmacokinetics of carbamazepine-phenobarbital interaction in patients with epilepsy.
    Sennoune S; Iliadis A; Bonneton J; Barra Y; Genton P; Mesdjian E
    Biopharm Drug Dispos; 1996 Mar; 17(2):155-64. PubMed ID: 8907722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacokinetic modeling of steady state clearance of carbamazepine and its epoxide metabolite from sparse routine clinical data.
    Jiao Z; Shi XJ; Zhao ZG; Zhong MK
    J Clin Pharm Ther; 2004 Jun; 29(3):247-56. PubMed ID: 15153086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
    Perucca E; Cloyd J; Critchley D; Fuseau E
    Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetics of carbamazepine in elderly patients.
    Punyawudho B; Ramsay ER; Brundage RC; Macias FM; Collins JF; Birnbaum AK
    Ther Drug Monit; 2012 Apr; 34(2):176-81. PubMed ID: 22406657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetics of felbamate in children.
    Kelley MT; Walson PD; Cox S; Dusci LJ
    Ther Drug Monit; 1997 Feb; 19(1):29-36. PubMed ID: 9029743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation and comparison of carbamazepine population pharmacokinetics using dried blood spot and plasma concentrations from people with epilepsy: the clinical implication.
    Kong ST; Lim SH; Chan E; Ho PC
    J Clin Pharmacol; 2014 Feb; 54(2):225-33. PubMed ID: 23996245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic modeling of carbamazepine based on clinical data from Serbian epileptic patients.
    Jankovic SM; Jovanovic D; Milovanovic JR
    Methods Find Exp Clin Pharmacol; 2008 Nov; 30(9):707-13. PubMed ID: 19229380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population pharmacokinetics of free carbamazepine in adult Omani epileptic patients.
    Deleu D; Aarons L; Ahmed IA
    Eur J Clin Pharmacol; 2001 Jun; 57(3):243-8. PubMed ID: 11497340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of CYP3A4/5 and ABCB1 genetic polymorphisms on carbamazepine metabolism and transport in Chinese patients with epilepsy treated with carbamazepine in monotherapy and bitherapy.
    Wang P; Yin T; Ma HY; Liu DQ; Sheng YH; Wang C; Zhou BT
    Epilepsy Res; 2015 Nov; 117():52-7. PubMed ID: 26421491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of the effect of carbamazepine and valproic acid on the pharmacokinetics and metabolic profile of topiramate at steady state in patients with epilepsy.
    Mimrod D; Specchio LM; Britzi M; Perucca E; Specchio N; La Neve A; Soback S; Levy RH; Gatti G; Doose DR; Maryanoff BE; Bialer M
    Epilepsia; 2005 Jul; 46(7):1046-54. PubMed ID: 16026556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.